Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema
about
Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a reviewCharacterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effectPlausible Roles for RAGE in Conditions Exacerbated by Direct and Indirect (Secondhand) Smoke Exposure.Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease.Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary diseaseCytokine inhibition in the treatment of COPD.Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary diseaseA Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.CCN1 secretion induced by cigarette smoking extracts augments IL-8 release from bronchial epithelial cells.A novel phenylcyclohex-1-enecarbothioamide derivative inhibits CXCL8-mediated chemotaxis through selective regulation of CXCR2-mediated signalling.Potential new drugs for therapy of chronic obstructive pulmonary disease.Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study.Retinoic acid fails to reverse emphysema in adult mouse models.Oxidative stress and airway inflammation in severe exacerbations of COPD.Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease.Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway.Gene therapy for chronic obstructive pulmonary disease: twilight or triumph?Role of CXCL5 in leukocyte recruitment to the lungs during secondhand smoke exposureInverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease.Inflammatory cells in the airways in COPD.Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers.Aspects on pathophysiological mechanisms in COPD.Inflammation and immune response in COPD: where do we stand?Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease.Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.New concepts in the pathobiology of chronic obstructive pulmonary diseaseOxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema.Pathogenesis of inflammation and repair in advanced COPD.Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.The novel compound Sul-121 inhibits airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease.PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis.Bacterial vaccines in chronic obstructive pulmonary disease: effects on clinical outcomes and cytokine levels.(-)-Epigallocatechin-3-gallate Reduces Cigarette Smoke-Induced Airway Neutrophilic Inflammation and Mucin Hypersecretion in Rats.Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke.Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations.Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.
P2860
Q28390078-F1D58B5E-0F85-44D4-B1BE-EBA04956EC8AQ28573767-92586495-96A2-4E3A-BC95-0826F1887ACFQ30235227-DD4CF5A9-A201-4807-BB16-AC3C897BDCBEQ33204248-D3A3BBC0-93F8-4D9B-9F3A-BE04F4CAC2F7Q33553600-3117317E-3B83-4348-9487-2BC09ADE136DQ33568552-1570E81B-A5C7-49C8-B18A-DEACE72656D5Q33768967-6F8436CF-8E23-4AF0-8600-8915410E6195Q34171117-3359E37B-EA81-4670-850D-9F88644BB06CQ34558199-215DA6AC-D31A-4E27-956D-AE5E5F6E7764Q34847260-3DFB5C03-20D4-471A-AF72-1B1E5C12ADC8Q35071967-E2F43A2F-7A66-408D-96DF-A75F58482FB3Q35164728-DF5FDAA2-B193-4DCD-A8E7-6224E81EFAECQ35171918-F6582A16-3ACE-46C3-89DC-9583BF58207CQ35536577-57C4C982-14DF-4AF6-AED2-37EF65A6C559Q35537579-7CFF905F-59C8-46FF-AA27-B8AE82BD9F28Q35794462-EFE9D035-AEF3-4541-AB0A-7D78D4DAF17EQ36027413-F5E7B477-D2A6-4236-9000-22251B1723A3Q36099456-07D97A4E-E9CD-449F-86E8-08266824BC23Q36110564-522BB301-C1F9-4B7E-B6EE-8C148B78FF87Q36120008-FE9683AC-93F5-47D2-8E4E-CE345CBE8E79Q36193793-785689AE-648B-4910-8BB1-B84D039ED440Q36203075-B8B8FBD6-BE7C-42CB-B525-DC71006881B5Q36871006-F8297CAF-30BA-448E-960D-3A2AD1898986Q36909567-11FCD620-81B2-4430-B039-0BF179DFE1EEQ37057836-AE421E41-8920-4D8A-9649-76AEE9F01A87Q37082574-F6D64AB5-41DA-407F-9B26-4D0215E9C9C1Q37144323-5EBC7454-5826-4266-AC52-50354B1E0331Q37144335-C5F618A0-6471-4B46-989D-0BE28782A357Q37153279-B767A41A-C00C-4F7F-8109-A54E2B1088EBQ37343918-1811F87A-149F-482E-B0A5-3F7D26C52D73Q37711524-337C1431-55EC-4E41-B52D-070ABDC689BFQ39321350-27A7C4BD-8808-469B-AA90-EB9BCF93FED1Q39733325-2107F68E-0FFE-4057-A578-33802E2D9EF9Q39793680-D070B149-471E-47AB-8D29-CE1ABCCDAEBFQ40060026-BEBA80EB-44D6-487A-9338-290B38CBA785Q41203086-AA1B05B8-B3FA-4BFA-8CFE-D1602A92C60EQ41439025-FE34B92C-26FE-44A1-B33D-62940B7A44E7Q41997669-43EC1782-CB47-49D8-BCDD-466A4CF63A5DQ42221260-0A5D2DF4-BAED-4ABE-AA26-A60D08182B73Q42527399-F8153718-734C-410B-A59A-9CC2E38B4F44
P2860
Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Increased levels of interleuki ...... eptible to pulmonary emphysema
@ast
Increased levels of interleuki ...... eptible to pulmonary emphysema
@en
type
label
Increased levels of interleuki ...... eptible to pulmonary emphysema
@ast
Increased levels of interleuki ...... eptible to pulmonary emphysema
@en
prefLabel
Increased levels of interleuki ...... eptible to pulmonary emphysema
@ast
Increased levels of interleuki ...... eptible to pulmonary emphysema
@en
P2093
P2860
P356
P1433
P1476
Increased levels of interleuki ...... eptible to pulmonary emphysema
@en
P2093
P2860
P304
P356
10.1136/THORAX.57.5.405
P407
P577
2002-05-01T00:00:00Z